Literature DB >> 12126802

Attitudes toward biotechnology in the European Union.

Rafael Pardo1, Cees Midden, Jon D Miller.   

Abstract

Public attitudes toward biotechnology in the European Union have been characterized as negative using Eurobarometer data, but so far little attention has been paid to building a robust metric appropriate for emerging public opinion issues which combine high salience with very limited knowledge by the public. On the basis of the general literature about the formation and structure of attitudes and about public perceptions of science, this article presents a new metric and analysis: first, for estimating the level of awareness and knowledge of biotechnology in Europe; second, for assessing the stability and depth of these evaluative perceptions; and third, for exploring the roles of canonical socio-demographic variables, the knowledge variable and general attitudinal schemas for understanding the perceptions of both benefits and risks of biotech applications. The results show the importance of general value orientations or "worldviews" in shaping positive attitudes, and more of these general cognitive schemas should be measured in future research. The same multivariate model was unable to account for a significant percentage of the total variance in the perception of risks, suggesting that new measures are needed to tap this critical area in the acceptance of biotech in Europe.

Entities:  

Mesh:

Year:  2002        PMID: 12126802     DOI: 10.1016/s0168-1656(02)00082-2

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  18 in total

1.  Principles of risk perception applied to gene technology.

Authors:  Lennart Sjöberg
Journal:  EMBO Rep       Date:  2004-10       Impact factor: 8.807

2.  Connecting the public with biobank research: reciprocity matters.

Authors:  Herbert Gottweis; George Gaskell; Johannes Starkbaum
Journal:  Nat Rev Genet       Date:  2011-10-18       Impact factor: 53.242

3.  Hypothetical and factual willingness to participate in biobank research.

Authors:  Linus Johnsson; Gert Helgesson; Thorunn Rafnar; Ingibjorg Halldorsdottir; Kee-Seng Chia; Stefan Eriksson; Mats G Hansson
Journal:  Eur J Hum Genet       Date:  2010-07-21       Impact factor: 4.246

4.  The role of means and goals in technology acceptance. A differentiated landscape of public perceptions of pharming.

Authors:  Rafael Pardo; Margret Engelhard; Kristin Hagen; Rikke Bagger Jørgensen; Eckard Rehbinder; Angelika Schnieke; Mariana Szmulewicz; Felix Thiele
Journal:  EMBO Rep       Date:  2009-09-18       Impact factor: 8.807

5.  Promoting public awareness and engagement in genome sciences.

Authors:  Susanne B Haga; Katie D Rosanbalm; Larry Boles; Genevieve M Tindall; Troy M Livingston; Julianne M O'Daniel
Journal:  J Genet Couns       Date:  2013-02-23       Impact factor: 2.537

6.  Factors influencing stakeholders attitudes toward genetically modified aedes mosquito.

Authors:  Latifah Amin; Hasrizul Hashim
Journal:  Sci Eng Ethics       Date:  2014-06-07       Impact factor: 3.525

7.  Predicting human cloning acceptability: a national Greek survey on the beliefs of the public.

Authors:  Georgia S Tzamalouka; Maria Papadakaki; Pelagia Soultatou; Sevasti Chatzifotiou; Basil Tarlatzis; Joannes El Chliaoutakis
Journal:  J Assist Reprod Genet       Date:  2005-10       Impact factor: 3.412

8.  Exploring the public understanding of basic genetic concepts.

Authors:  Angela D Lanie; Toby Epstein Jayaratne; Jane P Sheldon; Sharon L R Kardia; Elizabeth S Anderson; Merle Feldbaum; Elizabeth M Petty
Journal:  J Genet Couns       Date:  2004-08       Impact factor: 2.537

9.  Ethical and Methodological Considerations for Evaluating Participant Views on Alzheimer's and Dementia Research.

Authors:  Clark Benson; Amanda Friz; Shannon Mullen; Laura Block; Andrea Gilmore-Bykovskyi
Journal:  J Empir Res Hum Res Ethics       Date:  2020-11-26       Impact factor: 1.742

10.  Patients' refusal to consent to storage and use of samples in Swedish biobanks: cross sectional study.

Authors:  Linus Johnsson; Mats G Hansson; Stefan Eriksson; Gert Helgesson
Journal:  BMJ       Date:  2008-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.